Blatant antisemitic motives by BNP Paribas claimed by Jacob Agam in €1 Billion lawsuit filed by Farrugia, Gatt & Falzon
LONDON, March 06, 2019 (GLOBE NEWSWIRE) -- French bank BNP Paribas, its Chairman Jean Lemierre, CEO Jean Laurent Bonnafé and the bank’s legal representative Valérie Lafarge-Sarkozy are the subjects of a lawsuit filed on behalf of Jacob Agam and Vertical Group Holding Ltd by Farrugia, Gatt & Falzon in Malta on 1st March 2019 with a claim for damages estimated to reach €1 billion. The bank and the other Respondents are specifically accused in the Claim filed, of having conducted an alleged smear campaign against the plaintiffs Jacob Agam and his company Vertical Group, violating amongst others, statutory banking and defamation laws. The bank and other Respondents are accused of spreading damaging statements to the world’s media, falsely claiming in 2017 that the Plaintiffs “wriggled out” of financial obligations, which, according to the claim, never occurred. The bank’s alleged smear campaign, it is claimed, has destroyed the Plaintiffs’ pending transactions, professional reputation and credit standing, resulting in severe loss of business and the termination of transactions causing direct losses and damages estimated to reach €1 billion.
The bank’s actions, the Plaintiffs claim, were a part of a long-running dispute between the parties after Mr Agam persistently challenged the bank over its admission of and criminal conviction for its alleged antisemitic stance, as well as having conducted financial transactions with terrorist organisations acting against the State of Israel. The Plaintiffs are the Malta-based Vertical Group Holding Limited and its chairman and founder Jacob Agam, with whom BNP Paribas still maintains a client relationship, with all the banking responsibilities attached. According to the claim, the Plaintiffs have honoured all of their obligations as clients of the bank.
According to the claim filed, in 2014, following Mr Agam’s challenges regarding its antisemitic actions and financial transactions with terrorist organisations, and with the subsequent support of European and Israeli parliamentarians, as well as having highlighted the bank’s $40 million settlement with a former employee who was subjected to viewing imagery of Hitler in a positive context as part of an internal training video produced by the bank’s management in Europe, the bank responded with the abrupt termination of his companies’ investment facilities. The claim states that despite the bank’s apparent breaches, those facilities were fully honoured and paid by the Plaintiffs, with the bank’s acknowledgement.
The claim states that the bank’s representative, Ms Lafarge-Sarkozy, then sought to seize Mr Agam’s and his sister’s properties, stating in front of several witnesses during an open court hearing in late 2016 that she regards Jews as “ces gens-là”, or “these people”, a highly derogatory antisemitic phrase in the French language, which, according to her, defines Jewish people as “p arasites lounging around in luxurious estates living at the expense of the bank and a part of an international financial world”, echoing a dark chapter in history.
According to the lawsuit filed, Mr Agam claims that when he continued his challenge of the bank’s antisemitic actions, the bank unexpectedly chose, in late 2016, to engage a Jewish lawyer Jean Veil, from a known family of Holocaust survivors, who was instructed to solicit a written apology from Mr Agam for having challenged the bank over its pattern of antisemitic behaviour as a condition of reaching a settlement, or else the bank would exercise its power against him.
The bank’s CEO and Chairman, despite their knowledge of the case and multiple requests for their respective intervention, failed to act to, either condemn or prevent the alleged destructive smear campaign against the Plaintiffs and their respective assets and businesses, which led to a direct loss and damages estimated to reach €1 billion or more.
Jacob Agam commented: “As demonstrated in the past, the Respondents failed to see themselves accountable to the rule of law. The bank’s management must not and cannot hide behind its corporate veil to solicit and/or to condone all forms of racism. With its current misconduct, I fear a repeat of the bank’s past admissions, reaching new heights. I trust all relevant stakeholders, in particular the bank’s shareholders, will intervene to put a stop to the repeated misconducts by the bank and its management, which have been committed at the expense of the bank’s shareholders and clients.”
Dr. Pio M. Valletta of Maltese law firm Farrugia, Gatt & Falzon, who filed the lawsuit on behalf of Mr Agam and his company Vertical Group Holding Limited, commented: “BNP Paribas has long been accused of a systematic pattern of antisemitism. In my long professional career, the behaviour of BNP Paribas against my client Mr. Jacob Agam, his family and his assets including Vertical Group Holding Limited, stands out as amongst the most destructive behaviour by a bank against its clients, with ample evidences to be presented to the court as to the bank’s racial motives.”
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/4ac74dc9-ad22-44c9-8d8b-707311060635
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Følg saker fra GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra GlobeNewswire
Mohawk Industries Reports Q1 Results25.4.2019 22:15:00 CEST | Pressemelding
CALHOUN, Ga., April 25, 2019 (GLOBE NEWSWIRE) -- Mohawk Industries, Inc. (NYSE: MHK) today announced 2019 first quarter net earnings of $122 million and diluted earnings per share (EPS) of $1.67. Adjusted net earnings were $154 million, and EPS was $2.13, excluding restructuring, acquisition and other charges. Net sales for the first quarter of 2019 were $2.44 billion, up 1% in the quarter and 6% on a constant currency and days basis. For the first quarter of 2018, net sales were $2.41 billion, net earnings were $209 million and EPS was $2.78, adjusted net earnings were $225 million, and EPS was $3.01, excluding restructuring, acquisition and other charges. Commenting on Mohawk Industries’ first quarter performance, Jeffrey S. Lorberbaum, Chairman and CEO, stated, “In the first quarter, we delivered results in-line with the high end of our expectations despite economies weakening in most regions and a stronger U.S. dollar, reducing our translated results. While U.S. housing markets beg
Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 2, 201925.4.2019 22:05:00 CEST | Pressemelding
GAITHERSBURG, Md., April 25, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX) today announced it will report its first quarter 2019 financial and operating results following the close of U.S. financial markets on Thursday, May 2, 2019. Conference call details are as follows: Date: May 2, 2019 Time: 4:30 p.m. U.S. Eastern Time (ET) Dial-in number: (877) 212-6076 (Domestic) or (707) 287-9331 (International) Passcode: 5394082 Webcast: www.novavax.com, “Investors”/ “Events” Conference call and webcast replay: Dates: Starting at 7:30 p.m. ET, May 2, 2019 until 7:30 p.m. ET May 9, 2019 Dial-in number: (855) 859-2056 (Domestic) or (404) 537-3406 (International) Passcode: 5394082 Webcast: www.novavax.com, “Investors”/ “Events”, until August 2, 2019 About Novavax Novavax, Inc. (Nasdaq:NVAX) is a late-stage biotechnology company that drives improved health globally through the discovery, development, and commercialization of innovative vaccines to prevent serious infectious diseases. Its tw
Oxford Immunotec Schedules First Quarter 2019 Earnings Release and Conference Call for May 9, 201925.4.2019 22:05:00 CEST | Pressemelding
OXFORD, United Kingdom and MARLBOROUGH, Mass., April 25, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced that it plans to release first quarter 2019 financial results before the open of the market on Thursday, May 9, 2019. Dr. Peter Wrighton-Smith, Chief Executive Officer, and Matt McLaughlin, Chief Financial Officer, will host a conference call to review the Company's financial results at 8:00 a.m. Eastern Time the same day. The call will be concurrently webcast. To listen to the conference call on your telephone, please dial (855) 363-5047 for United States callers or +1 (484) 365-2897 for international callers and reference confirmation code 6687808, approximately ten minutes prior to start time. To access the live audio webcast or subsequent archived recording, visit the Investor Relations section of Oxford Immunotec's website at www.oxfordimmunotec.com. The replay will be available on th
BGRS Acquired by Relo Group, Inc.25.4.2019 17:55:00 CEST | Pressemelding
CHICAGO and TOKYO, April 25, 2019 (GLOBE NEWSWIRE) -- Relo Group, Inc. (“Relo Group”) and BGRS (“BGRS” or the “Company”) announced today that they have entered into a definitive agreement under which an affiliate of Relo Group will acquire BGRS, a leading global talent mobility management firm from Brookfield Business Partners. Leading the global mobility industry with innovative outsourcing and fully integrated solutions, BGRS provides a full spectrum of talent mobility and advisory services to Global Fortune 500 companies. Supported by a team of over 1,300 globally, BGRS manages over 60,000 employee relocations annually with locations throughout Asia, the Americas and EMEA. BGRS Chief Executive Officer, Traci Morris, and the management team will remain in place and work with Relo Group to advance the Company into its next phase. “BGRS has developed into a world class talent mobility management firm by always putting the interests of our clients first, constantly innovating and search
Ascom adds ‘talk before walk’ wireless speech function to new release of Ascom teleCARE IP25.4.2019 14:00:00 CEST | Pressemelding
New feature helps reduce caregivers’ walking time; enables more streamlined workflows in elderly care facilities BAAR, Switzerland, April 25, 2019 (GLOBE NEWSWIRE) -- Ascom (SWX:ASCN.SW), a global solutions provider focused on healthcare ICT and mobile workflow solutions, has added wireless speech functionality to its latest version of the Ascom teleCARE IP emergency call system. The new feature promises to help reduce the time spent by staff walking to investigate calls from residents in continuing and elderly care facilities. Ascom teleCARE IP has always had hardwired speech functionality. But by making it wireless, residents can simply use their normal mobile phones to communicate directly with caregivers via Ascom teleCARE IP. Caregivers can communicate with residents while on the go, and can deal with residents’ calls before walking to investigate. The newly released (Ascom teleCARE IP 12) is available globally. The latest version also features several technical enhancements inclu
LGC CAPITAL announces conditional approval of an amended private placement financing of $10,400,000 with Arlington Capital LP25.4.2019 14:00:00 CEST | Pressemelding
MONTRÉAL, April 25, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSXV: LG) (OTCQB: LGGCF) ("LGC") is pleased to announce that it has obtained conditional approval from the TSX Venture Exchange for its previously announced financing with Arlington Capital (please refer to LGC’s press release dated January 24, 2019). Since that announcement, both parties have agreed to increase the financing to $10.4 million from the previously announced $8 million. Pursuant to the private placement, Arlington Capital will subscribe for a total of 104,000,000 common shares of LGC at a price of $0.10 per share. As a result of this private placement, Arlington Capital will, on closing, become LGC’s largest shareholder holding 19.97% of LGC’s issued and outstanding common shares. There are no warrants with this financing. Use of proceeds are to accelerate LGC’s group of companies’ business plan for the current calendar year. As previously announced, on closing of the private placement, LGC will pay a 3% finde